Avi Naider is President of AI Life Sciences, a Life Sciences and MedTech investment group affiliated with Access Industries.

Avi is a serial entrepreneur and operator who has grown several companies from startup to exit, and in various industries including internet advertising, fintech and biotech.

He served on the Board of Loxo Oncology (LOXO) from its founding until sale to Eli Lilly (LLY) in 2019 and currently serves on the boards of several private companies. He holds a BA with honors from Princeton University and began his career with the Boston Consulting Group (BCG).